jeudi 16 novembre 2017

Onco Actu du 16 novembre 2017

3.1.1 Prévention - Tabac - e-cigs

'Vaping should be part of support' to help smokers with mental health conditions quit [Cancer Research UK]

3.7 Prévention - Alcool

Minimum alcohol pricing in Scotland gets go ahead [Cancer Research UK]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

FDA Announces Third-Party Review Pathway for Tumor Profiling Tests [RAPS]

FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action [FDA]

FDA Authorizes MSK-IMPACT Test for Analyzing Patient Tumors [Memorial Sloan Kettering Cancer Center]

5. Traitements

Pancreatic cancer is often deadly. But recent discoveries are starting to unravel its mysteries — and raise hope [STAT]

5.12 Immunothérapies

Powerful new cancer drugs are saving lives, but can also ignite diabetes or other autoimmune conditions [Science]

5.12.2 Immunothérapies - CAR-T

Promising new CAR-T therapy able to target T-cell lymphoma [Pharmafile]

5.12.7 Immunothérapies - vaccins

This $5 Billion Startup Made Its First Cancer Vaccine—For Just One Person [Bloomberg]

5.2 Pharma

Takeda leverages lung cancer awareness month to highlight ALK variant [FiercePharma]

5.2.3 Pharma - économie

AstraZeneca, Merck, Clovis and Tesaro, all vying for share, may all win on faster PARP growth [FiercePharma]

5.4 Traitements - Economie

Breast cancer patients to have routine access to two life extending drugs after new deal, say NICE in draft guidance [NICE]

Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use [The Guardian]

Pfizer, Novartis agree UK price cuts for new breast cancer drugs [Reuters]

6. Lutte contre les cancers

Cancer Care in Low-Resource Areas: Cancer Treatment, Palliative Care, and Survivorship Care: Proceedings of a Workshop (2017) [NAP]

Novartis, ASCP and ACS join forces to fight cancer in Ethiopia, Uganda and Tanzania [ACS]

6.1 Observation

African-American Women With Type 2 Diabetes May Have Higher Risk for ER-negative Breast Cancer [AACR]

6.11 Patients

Tom Marsilje, a relentless advocate for cancer patients, dies at 45 [STAT]

6.12 Ethique

Bioethics: Justice in genomics [Nature]

6.6 Publications

Is There a Business Case for Open Data? [The Scholarly Kitchen]

6.9 Controverses

Placebo Myths Debunked [Science-Based Medicine]

Economics: How science got a golden ticket [Nature]